MétaCan
Menu
Back to cohort
Record W1766945816 · doi:10.18632/oncotarget.1627

Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours

2014· article· en· W1766945816 on OpenAlexafffundabout
Rebecca Martin, Martin Kerr, Mark Teo, Sarah J. Jevons, Marianne Koritzinsky, Bradly G. Wouters, Selina Bhattarai, Anne E. Kiltie

Bibliographic record

VenueOncotarget · 2014
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
FundersCanadian Institutes of Health ResearchNational Institute for Health and Care ResearchCancer Research UK
KeywordsBladder cancerCystectomyMedicinemicroRNARadiation therapyCancerCancer researchPathologyOncologyInternal medicineBiologyGeneGenetics

Abstract

fetched live from OpenAlex

// Rebecca M. Martin 1 , Martin Kerr 1 , Mark T.W. Teo 2 , Sarah J. Jevons 1 , Marianne Koritzinsky 3 , Bradly G. Wouters 3 , Selina Bhattarai 4 , Anne E. Kiltie 1 1 Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, UK 2 Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds, UK 3 Princess Margaret Cancer Centre, University Health Network, Toronto, Canada and Department of Radiation Oncology, University of Toronto, Toronto, Canada 4 Department of Histopathology and Molecular Pathology, St James’s University Hospital, Leeds, UK Correspondence: Anne E Kiltie, email: // Key words : MRE11, bladder cancer, post-transcriptional regulation, microRNA, miR-153, protein stability Received : November 25, 2013 Accepted : January 14, 2014 Published : January 14, 2014 Abstract Predictive assays are needed to help optimise treatment in muscle-invasive bladder cancer, where patients can be treated by either cystectomy or radical radiotherapy. Our finding that low tumour MRE11 expression is predictive of poor response to radiotherapy but not cystectomy was recently independently validated. Here we investigated further the mechanism underlying low MRE11 expression seen in poorly-responding patients. MRE11 RNA and protein levels were measured in 88 bladder tumour patient samples, by real-time PCR and immunohistochemistry respectively, and a panel of eight bladder cancer cell lines was screened for MRE11, RAD50 and NBS1 mRNA and protein expression. There was no correlation between bladder tumour MRE11 protein and RNA scores (Spearman’s rho 0.064, p=0.65), suggesting MRE11 is controlled post-transcriptionally, a pattern confirmed in eight bladder cancer cell lines. In contrast, NBS1 and RAD50 mRNA and protein levels were correlated (p=0.01 and p=0.03, respectively), suggesting primary regulation at the level of transcription. MRE11 protein levels were correlated with NBS1 and RAD50 mRNA and protein levels, implicating MRN complex formation as an important determinant of MRE11 expression, driven by RAD50 and NBS1 expression. Our findings of the post-transcriptional nature of the control of MRE11 imply that any predictive assays used in patients need to be performed at the protein level rather than the mRNA level.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.261
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2014
Admission routes3
Has abstractyes

Explore more

Same venueOncotargetSame topicBladder and Urothelial Cancer TreatmentsFrench-language works237,207